Lori Wirth, MD is an Assistant Professor in Medicine at Harvard Medical School, and joined Massachusetts General Hospital in 2008 to become the Medical Director of the Center for Head and Neck Cancers.
Dr. Wirth attending Brown University as an undergraduate, then obtained her MD from Columbia University College of Physicians and Surgeons, where she had the distinction of being nominated to Alpha Omega Alpha Honor Medical Society. Dr. Wirth was a fellow in Hematology/Oncology at Harvard's Dana-Farber/Partners CancerCare Fellowship Program. Dr. Wirth was on staff in Head and Neck Oncology at the Dana-Farber Cancer Institute in Boston.
Dr. Wirth is a leading authority in head and neck oncology, with special expertise in combined modality therapy for cancers of the head and neck, and new treatments for advanced thyroid cancers. She sits on national and international committees that guide cancer treatment and research efforts.